135 related articles for article (PubMed ID: 35348420)
1. Reply to Akin
Leisman DE; Mehta A; Thompson BT; Hacohen N; Filbin MR; Goldberg MB
Am J Respir Crit Care Med; 2022 May; 205(10):1253-1254. PubMed ID: 35348420
[No Abstract] [Full Text] [Related]
2. High Renin Concentrations in Severe COVID-19 Are Indicative for a Hypo-Renin-Angiotensin-System State.
Akin S; Schriek P; van Nieuwkoop C; Neuman RI; Verdonk K; Danser AHJ
Am J Respir Crit Care Med; 2022 May; 205(10):1252-1253. PubMed ID: 35348428
[No Abstract] [Full Text] [Related]
3. Response by Gheblawi et al to Letter Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2".
Gheblawi M; Wang K; Viveiros A; Nguyen Q; Zhong JC; Turner AJ; Raizada MK; Grant MB; Oudit GY
Circ Res; 2020 Jul; 127(2):e46-e47. PubMed ID: 32614719
[No Abstract] [Full Text] [Related]
4. Commentary to Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
Ferri C; Desideri G; Del Pinto R
High Blood Press Cardiovasc Prev; 2021 May; 28(3):251-252. PubMed ID: 33792849
[No Abstract] [Full Text] [Related]
5. Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy.
Tomasoni D; Petrie MC; Adamo M; Metra M
Eur J Heart Fail; 2021 Mar; 23(3):486-488. PubMed ID: 33421242
[No Abstract] [Full Text] [Related]
6. [Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].
Kreutz R; Abd El-Hady Algharably E; Ganten D; Messerli F
Pneumologie; 2020 Sep; 74(9):611-614. PubMed ID: 32916743
[No Abstract] [Full Text] [Related]
7. [Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers].
Mareev YV; Mareev VY
Kardiologiia; 2020 Apr; 60(4):4-9. PubMed ID: 32394850
[TBL] [Abstract][Full Text] [Related]
8. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
Speth RC
Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
[No Abstract] [Full Text] [Related]
9. Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences.
Dettlaff-Pokora A; Swierczynski J
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925881
[TBL] [Abstract][Full Text] [Related]
10. Renin--angiotensin system blockers and the risk of critical or fatal coronavirus disease 2019 in African Americans.
Thomopoulos C; Michalopoulou H
J Hypertens; 2020 Dec; 38(12):2384-2386. PubMed ID: 33149061
[No Abstract] [Full Text] [Related]
11. Letter by Weir Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2".
Weir RAP
Circ Res; 2020 Jul; 127(2):e44-e45. PubMed ID: 32614717
[No Abstract] [Full Text] [Related]
12. [Renin-angiotensin-aldosterone blockers and Covic-19 infection : friends or enemies ?].
Pechère-Bertschi A; Ponte B; Wuerzner G
Rev Med Suisse; 2020 May; 16(693):1003-1007. PubMed ID: 32401442
[TBL] [Abstract][Full Text] [Related]
13. Update Alert 6: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
Mackey K; Kansagara D; Vela K
Ann Intern Med; 2021 Jan; 174(1):W17. PubMed ID: 33253036
[No Abstract] [Full Text] [Related]
14. Association between angiotensin blockade and COVID-19 severity in Hong Kong.
Cheung KS; Hung IFN; Leung WK
CMAJ; 2020 Jun; 192(23):E635. PubMed ID: 32575056
[No Abstract] [Full Text] [Related]
15. Reply to Siniorakis et al., "COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure".
Fedson DS; Opal SM; Rordam OM
mBio; 2020 May; 11(3):. PubMed ID: 32471831
[No Abstract] [Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers benefits outweigh the risks in COVID-19 hypertensive patients.
Ateya AM; Sabri NA
J Med Virol; 2021 Apr; 93(4):1873-1874. PubMed ID: 33200431
[No Abstract] [Full Text] [Related]
17. Mechanical dependency of the SARS-CoV-2 virus and the renin-angiotensin-aldosterone (RAAS) axis: a possible new threat.
Sen R; Sengupta D; Mukherjee A
Environ Sci Pollut Res Int; 2022 Sep; 29(41):62235-62247. PubMed ID: 34859345
[TBL] [Abstract][Full Text] [Related]
18. Could renin-angiotensin-aldosterone system inhibitors be used for hypertensive patients with coronavirus disease 2019?
Liu D; Li YZ; Wu H
J Hypertens; 2020 Jun; 38(6):1191-1192. PubMed ID: 32371813
[No Abstract] [Full Text] [Related]
19. Covid-19 and the angiotensin-converting enzyme (ACE2): Areas for research.
Omar MB
Heart Lung; 2020; 49(4):351. PubMed ID: 32327200
[No Abstract] [Full Text] [Related]
20. The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients.
Zamai L
Cells; 2020 Jul; 9(7):. PubMed ID: 32708755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
